PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia

Pooled data from three donors suggested TIGIT blockade, but not PVRIG blockade, decreased the NK:target ratio required for 10% lysis, but the difference did not reach statistical significance ( Figure 1G ).

also in 111,027 other papers